about
Tricuspid valve interventions: surgical techniques and outcomesCoronary artery bypass grafting: Part 1--the evolution over the first 50 yearsThe future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?Coronary artery bypass grafting: Part 2--optimizing outcomes and future prospectsDestination therapy--time for a paradigm change in heart failure therapyProlonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart SurgeryESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with theAnastomotic Devices in Coronary Artery Bypass Grafting.Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendagePrediction of the annuloplasty ring size in patients undergoing mitral valve repair using real-time three-dimensional transoesophageal echocardiographyThe endovascular occlusion system for safe and immediate peripheral vessel occlusion during vascular interventions.The value of surgeon-specific outcome data: results of a questionnaire.Left Main Artery Thrombus Complicating Heart Transplantation in a Patient With Heparin-Induced Thrombocytopenia.Living-engineered valves for transcatheter venous valve repair.Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryRevascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.Degenerative mitral valve regurgitation: best practice revolutionRetrospective analysis of outcome data with regards to the use of Phisio®-, Bioline®- or Softline®-coated cardiopulmonary bypass circuits in cardiac surgery.Safety and feasibility of novel technology fusing echocardiography and fluoroscopy images during MitraClip interventions.2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributImplantation of personalized, biocompatible mitral annuloplasty rings: feasibility study in an animal model.Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept studyESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with theTransvenous lead extractions: comparison of laser vs. mechanical approach.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribDyna-CT during minimally invasive off-pump transapical aortic valve implantation.Diastolic aorto-right-atrial fistulation in aortic and tricuspid valve endocarditis.Pancreatic stone protein predicts postoperative infection in cardiac surgery patients irrespective of cardiopulmonary bypass or surgical technique.Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.The cytoprotective capacity of processed human cardiac extracellular matrix.Calcification Characteristics of Low-Flow Low-Gradient Severe Aortic Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement.Augmented reality for intraoperative guidance in endoscopic coronary artery bypass grafting.Minimally invasive surgery for valve disease.Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement.Laparoscopic sleeve gastrectomy at a new bariatric surgery centre in Canada: 30-day complication rates using the Clavien-Dindo classification.Interhospital transfer of seriously sick ARDS patients using veno-venous Extracorporeal Membrane Oxygenation (ECMO): Concept of an ECMO transport teamLate pharmacologic conditioning with volatile anesthetics after cardiac surgery.HEARTSTRING enabled no-touch proximal anastomosis for off-pump coronary artery bypass grafting: current evidence and technique.Evaluation of calcium loss after transcatheter aortic valve implantation.
P50
Q26783345-3C1A6C33-3B4F-4117-8AE4-38CA65151BBAQ26830855-38020489-12A7-4DD3-980E-531D5979FD63Q26860834-D466B1D2-ECC3-453E-BAB5-DCBD833C3D09Q26996250-D73F0F2D-E828-43B6-AB0D-F97836523BB6Q27015070-3F77E63D-5B1C-4B5F-80F9-98EB41F57DE6Q28258684-0028B44E-7532-44AF-AA43-05C9562D45A3Q28267062-D5C6E5A8-73ED-41C1-B645-CB74874068FAQ30313264-8923FD2A-032C-428C-A710-86A8FFE9ABDBQ30417404-D77EBFE2-5315-439B-8FA1-B0ECD3BCC6E7Q30501258-307655E9-A413-4879-A14B-465390B7BC5CQ30552583-79A3708A-CCDB-4952-98ED-5E0426789028Q31103226-662F06C2-A4BA-451F-B8F0-44C2516E056BQ33433989-2992E1CA-CEE9-402E-9FF1-F65712936948Q33631564-A5503271-BD93-41CE-8C32-87E6ADAA51B7Q33755419-8D5F32A5-F0A8-4B0B-8679-E9C86B9C2D10Q33791885-9E765672-8D13-4F3C-BECB-D96EA7BF0E7DQ34065282-8B62E534-44CE-4B45-AF26-AB1BB4598B6CQ34366543-04AE6003-C2C7-4A70-B1BE-19CAB4CFD087Q34376144-9A7B3F37-8E69-4E5B-9A83-88DC35A7459BQ34491530-22828E65-CD2B-4351-AEA0-4FDA0B4BFB15Q34527664-6F23D705-C347-495E-A309-B7934C517A45Q34536163-483F6D59-37C9-4A0E-A4BE-0C02DE77E704Q34637607-A4ADBAD1-D672-48EF-A87B-1895A5633C99Q34640762-F199E94C-E684-4087-A859-9FF27331EFF7Q34667562-85272802-3964-4B5C-B47E-19CB02B79056Q34677347-83AE0DAB-C0B6-47C4-BB97-F4D916DECA4AQ35014156-B87FC44A-7662-4E2F-B4D1-744E10203394Q35179579-8BE0F86A-200E-4C79-B992-4EA070B85597Q35203274-DA1CAC0A-6BA2-4BEB-A1A5-8CE527FB219DQ35779127-71AA6527-068C-4897-80A0-5120FB3DBDB0Q36044091-E6C10C18-8376-4E31-A4DE-F4941EB233C2Q36075723-8A0FED57-FB42-4959-A6FC-7D5E9897074BQ36417004-81C693A1-688F-47AD-BF25-D825505B294CQ36477488-42DCC7A3-6C26-4816-876F-DBACD0B82066Q36490890-AD0CA20E-1B91-45B4-B02A-014FE7329EF6Q36746338-6024A2F2-6F86-41C2-AD07-5370C4131C17Q36879555-F1A571F0-ACB0-4F31-A6B4-5FADFB2056CEQ36928217-43E17B25-2485-474A-9D88-AC56F882EE54Q37099194-11F1FBFE-6234-447C-86CD-02F85229499AQ37401209-05B80086-4BDA-43BC-8ABE-048F38D0622E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Volkmar Falk
@ast
Volkmar Falk
@en
Volkmar Falk
@es
Volkmar Falk
@nl
Volkmar Falk
@sl
type
label
Volkmar Falk
@ast
Volkmar Falk
@en
Volkmar Falk
@es
Volkmar Falk
@nl
Volkmar Falk
@sl
prefLabel
Volkmar Falk
@ast
Volkmar Falk
@en
Volkmar Falk
@es
Volkmar Falk
@nl
Volkmar Falk
@sl
P106
P21
P214
3822148209308600460003
P31
P496
0000-0002-7911-8620
P734
P7859
viaf-3822148209308600460003